Literature DB >> 22116294

Cancer stem cell hypotheses: impact on modern molecular physiology and pharmacology research.

Igor Pantic1.   

Abstract

Although questioned on several occasions, the existence of cancer stem cells (CSCs) has been confirmed by a number of studies on experimental animal models. Nevertheless, it was shown that CSC hypotheses have several limitations and inconsistencies regarding the explanation of CSC origin, CSC identification and isolation, possible heterogeneity within CSC population, as well as methodology issues in some studies that were carried out in order to prove CSC existence. The aim of this article is to give a short and comprehensive review of recent advances concerning CSC hypothesis and to describe its impact on modern molecular physiology and pharmacology research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116294     DOI: 10.1007/s12038-011-9155-5

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  33 in total

1.  Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling.

Authors:  Christine M Fillmore; Piyush B Gupta; Jenny A Rudnick; Silvia Caballero; Patricia J Keller; Eric S Lander; Charlotte Kuperwasser
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 2.  Cancer stem cells: mirage or reality?

Authors:  Piyush B Gupta; Christine L Chaffer; Robert A Weinberg
Journal:  Nat Med       Date:  2009-09-04       Impact factor: 53.440

3.  Targeting of CD44 eradicates human acute myeloid leukemic stem cells.

Authors:  Liqing Jin; Kristin J Hope; Qiongli Zhai; Florence Smadja-Joffe; John E Dick
Journal:  Nat Med       Date:  2006-09-24       Impact factor: 53.440

Review 4.  Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.

Authors:  Naoko Takebe; Pamela J Harris; Ronald Q Warren; S Percy Ivy
Journal:  Nat Rev Clin Oncol       Date:  2010-12-14       Impact factor: 66.675

5.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

Authors:  Catherine A O'Brien; Aaron Pollett; Steven Gallinger; John E Dick
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

Review 6.  First among equals: the cancer cell hierarchy.

Authors:  Christine V Ichim; Richard A Wells
Journal:  Leuk Lymphoma       Date:  2006-10

7.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

Review 8.  Understanding the cancer stem cell.

Authors:  S Bomken; K Fiser; O Heidenreich; J Vormoor
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

9.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

10.  Tumor growth need not be driven by rare cancer stem cells.

Authors:  Priscilla N Kelly; Aleksandar Dakic; Jerry M Adams; Stephen L Nutt; Andreas Strasser
Journal:  Science       Date:  2007-07-20       Impact factor: 47.728

View more
  11 in total

Review 1.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

Review 2.  Prognostic value of cancer stem cell marker CD133 in ovarian cancer: a meta-analysis.

Authors:  Quan Zhou; Aihua Chen; Huamei Song; Jing Tao; Huaijie Yang; Manzhen Zuo
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?

Authors:  Alireza Mirzaei; Gholamreza Tavoosidana; Afshin Abdi Rad; Farhad Rezaei; Masoumeh Tavakoli-Yaraki; Azade Amini Kadijani; Ehsan Khalili; Zahra Madjd
Journal:  Tumour Biol       Date:  2015-09-17

Review 4.  Colon cancer stem cells: controversies and perspectives.

Authors:  Maria Ausiliatrice Puglisi; Valentina Tesori; Wanda Lattanzi; Giovanni Battista Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

Review 5.  Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.

Authors:  Marta Szajnik; Małgorzata Czystowska-Kuźmicz; Esther Elishaev; Theresa L Whiteside
Journal:  Expert Rev Mol Diagn       Date:  2016-06-23       Impact factor: 5.225

6.  Major Protein of Carcinoembryonic Antigen Gene Family - CD66c, A Novel Marker in Colon Carcinoma.

Authors:  Suma M Nataraj; Chaitra Linganna Prema; Manjunath Gubbanna Vimalambike; Sheeladevi Chandakavadi Shivalingaiah; Shivakumar Sundaram; Anjali Pradeep Kumar; Ananda Kuruvatti Math; Akila Prashant
Journal:  J Clin Diagn Res       Date:  2016-02-01

Review 7.  MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown.

Authors:  Maria Braoudaki; George I Lambrou
Journal:  J Hematol Oncol       Date:  2015-02-06       Impact factor: 17.388

8.  Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-Gli.

Authors:  Jin-Bin Han; Feng Sang; Jin-Jia Chang; Yong-Qiang Hua; Wei-Dong Shi; Li-Hua Tang; Lu-Ming Liu
Journal:  Onco Targets Ther       Date:  2013-08-19       Impact factor: 4.147

9.  Nodal promotes the self-renewal of human colon cancer stem cells via an autocrine manner through Smad2/3 signaling pathway.

Authors:  Yuehua Gong; Ying Guo; Yanan Hai; Hao Yang; Yang Liu; Shi Yang; Zhenzhen Zhang; Meng Ma; Linhong Liu; Zheng Li; Zuping He
Journal:  Biomed Res Int       Date:  2014-02-17       Impact factor: 3.411

10.  Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma.

Authors:  Jaime Antonio Oliver; Raúl Ortiz; Consolación Melguizo; Pablo Juan Alvarez; Jaime Gómez-Millán; Jose Prados
Journal:  BMC Cancer       Date:  2014-07-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.